Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Losartan effective in chronic renal allograft rejection

May 28, 1997

MC-1288 + ciclosporin for allograft rejection

May 26, 1997

Highlights of the 7th INWIN

May 26, 1997

North American Vaccine cleared to initiate trials of meningitis vaccine

May 22, 1997

Malononitrilamides associated with potent immunosuppressive effects in animal models

May 22, 1997

VX-497: selective IMPDH inhibitor with potent immunosuppressive properties

May 22, 1997

PNP inhibitors from Chiroscience for T-cell-mediated disorders

May 21, 1997

Wyeth-Ayerst and NanoSystems agree to develop new formulation of Rapamune

May 20, 1997

Roche and Protein Design Labs report encouraging results from Zenapax trial

May 20, 1997

Phase I/II results for promising compound from BioTransplant and MedImmune

May 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...